Several other research analysts also recently commented on ISRG. BidaskClub raised Intuitive Surgical from a buy rating to a strong-buy rating in a research note on Friday, June 23rd. Cantor Fitzgerald started coverage on Intuitive Surgical in a research note on Thursday, June 29th. They issued a neutral rating and a $111.11 price objective for the company. Leerink Swann reissued an outperform rating on shares of Intuitive Surgical in a research note on Wednesday, July 5th. Canaccord Genuity reissued a hold rating and issued a $96.67 price objective on shares of Intuitive Surgical in a research note on Tuesday, July 11th. Finally, Royal Bank Of Canada increased their price objective on Intuitive Surgical from $88.89 to $105.56 and gave the company a sector perform rating in a research note on Tuesday, July 18th. Five analysts have rated the stock with a hold rating, thirteen have issued a buy rating and one has issued a strong buy rating to the company’s stock. The company currently has an average rating of Buy and a consensus target price of $150.10.
Shares of Intuitive Surgical (NASDAQ ISRG) opened at 357.46 on Monday. Intuitive Surgical has a 12 month low of $203.57 and a 12 month high of $367.50. The company has a 50-day moving average of $349.66 and a 200 day moving average of $312.64. The company has a market cap of $39.84 billion, a PE ratio of 51.37 and a beta of 0.39.
Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Monday, October 16th. The medical equipment provider reported $2.77 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.99 by $0.78. Intuitive Surgical had a return on equity of 15.99% and a net margin of 28.44%. The firm had revenue of $806.10 million during the quarter, compared to the consensus estimate of $753.25 million. During the same period in the prior year, the company earned $2.06 EPS. The firm’s revenue was up 18.0% compared to the same quarter last year. On average, analysts anticipate that Intuitive Surgical will post $7.93 earnings per share for the current year.
In related news, VP Jamie Samath sold 242 shares of the firm’s stock in a transaction dated Tuesday, July 25th. The stock was sold at an average price of $949.01, for a total transaction of $229,660.42. Following the completion of the sale, the vice president now directly owns 23 shares of the company’s stock, valued at approximately $21,827.23. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Salvatore Brogna sold 899 shares of the firm’s stock in a transaction dated Friday, September 1st. The stock was sold at an average price of $1,001.90, for a total value of $900,708.10. Following the sale, the executive vice president now directly owns 570 shares of the company’s stock, valued at $571,083. The disclosure for this sale can be found here. Insiders have sold a total of 23,172 shares of company stock valued at $21,923,487 over the last three months. Corporate insiders own 2.20% of the company’s stock.
Large investors have recently modified their holdings of the stock. Guardian Life Insurance Co. of America increased its position in shares of Intuitive Surgical by 2.2% during the 1st quarter. Guardian Life Insurance Co. of America now owns 142 shares of the medical equipment provider’s stock worth $109,000 after purchasing an additional 3 shares during the last quarter. ETF Managers Group LLC acquired a new stake in shares of Intuitive Surgical during the 2nd quarter worth about $110,000. D. Scott Neal Inc. acquired a new stake in shares of Intuitive Surgical during the 2nd quarter worth about $120,000. Harvest Fund Management Co. Ltd acquired a new stake in shares of Intuitive Surgical during the 2nd quarter worth about $120,000. Finally, Parallel Advisors LLC increased its position in shares of Intuitive Surgical by 10.1% during the 1st quarter. Parallel Advisors LLC now owns 153 shares of the medical equipment provider’s stock worth $129,000 after purchasing an additional 14 shares during the last quarter. 31.41% of the stock is owned by hedge funds and other institutional investors.
About Intuitive Surgical
Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.
Receive News & Ratings for Intuitive Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical Inc. and related companies with our FREE daily email newsletter.